Latest News by Industry
HERCULES, Calif.--(BUSINESS WIRE)--Oct 31, 2022--
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a Fireside Chat event during the Credit Suisse 31 st Annual Healthcare Conference on Tuesday, November 8, 2022, at 11:00 AM (PST).
A link to a live webcast of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With 70 years of focus on quality and customer service, our products advance the scientific discovery process and improve healthcare. Our customers are universities, research institutions, hospitals, biotechnology and pharmaceutical companies, as well as public health and commercial laboratories including food safety and environmental quality testing facilities. Based in Hercules, California, Bio-Rad has a global network of operations with approximately 8,200 employees worldwide and $2.9 billion in revenues in 2021. For more information, please visit bio-rad.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20221031005173/en/
CONTACT: Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.comMedia Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: RESEARCH MEDICAL DEVICES MEDICAL SUPPLIES CLINICAL TRIALS HEALTH TECHNOLOGY BIOTECHNOLOGY PHARMACEUTICAL HEALTH SCIENCE OTHER SCIENCE
SOURCE: Bio-Rad Laboratories, Inc.
Copyright Business Wire 2022.
PUB: 10/31/2022 08:30 AM/DISC: 10/31/2022 08:32 AM
http://www.businesswire.com/news/home/20221031005173/en